CGenetix Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $255K

  • Investors
  • 4

CGenetix General Information

Description

Operator of a molecular diagnostic company intended to offer non-invasive monitoring of transplant patients' organ health. The company offers liquid biopsy-based testing, epigenetic analysis, and digital polymerase chain reaction technologies, enabling healthcare providers to detect organ damage early, and improving patient care and quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 14, rue de la Grange aux Belles
  • 75010 Paris
  • France
+33 06
Primary Industry
Biotechnology
Other Industries
Other Healthcare Services
Vertical(s)
Corporate Office
  • 14, rue de la Grange aux Belles
  • 75010 Paris
  • France
+33 06

CGenetix Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CGenetix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 13-Nov-2025 $255K Completed Generating Revenue
3. Seed Round 15-Sep-2024 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Sep-2023 Completed Generating Revenue
1. Accelerator/Incubator 25-Oct-2022 Completed Generating Revenue
To view CGenetix’s complete valuation and funding history, request access »

CGenetix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
ABSA 2025
ABSA 2024
To view CGenetix’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

CGenetix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a molecular diagnostic company intended to offer non-invasive monitoring of transplant patients' organ healt
Biotechnology
Paris, France
6 As of 2025

Brisbane, CA
 

Austin, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CGenetix Competitors (4)

One of CGenetix’s 4 competitors is CareDx, a Formerly VC-backed company based in Brisbane, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CareDx Formerly VC-backed Brisbane, CA
Natera Formerly VC-backed Austin, TX
Insight Molecular Diagnostics Formerly VC-backed Nashville, TN
Eurofins Viracor Formerly PE-Backed Lenexa, KS
To view CGenetix’s complete competitors history, request access »

CGenetix Patents

CGenetix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260357344-A1 Method for characterising the degradation of an organ Pending 19-Sep-2022
EP-4590858-A1 Method for characterizing the degradation of an organ Pending 19-Sep-2022
WO-2024061826-A1 Method for characterizing the degradation of an organ Inactive 19-Sep-2022 C12Q1/6883

CGenetix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CGenetix Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
BSV Ventures Venture Capital Minority
Calyseed Venture Capital Minority
Paris Biotech Sante Accelerator/Incubator
Genopole Accelerator/Incubator
To view CGenetix’s complete investors history, request access »

CGenetix FAQs

  • When was CGenetix founded?

    CGenetix was founded in 2022.

  • Where is CGenetix headquartered?

    CGenetix is headquartered in Paris, France.

  • What is the size of CGenetix?

    CGenetix has 6 total employees.

  • What industry is CGenetix in?

    CGenetix’s primary industry is Biotechnology.

  • Is CGenetix a private or public company?

    CGenetix is a Private company.

  • What is the current valuation of CGenetix?

    The current valuation of CGenetix is .

  • What is CGenetix’s current revenue?

    The current revenue for CGenetix is .

  • How much funding has CGenetix raised over time?

    CGenetix has raised $611K.

  • Who are CGenetix’s investors?

    BSV Ventures, Calyseed, Paris Biotech Sante, and Genopole have invested in CGenetix.

  • Who are CGenetix’s competitors?

    CareDx, Natera, Insight Molecular Diagnostics, and Eurofins Viracor are competitors of CGenetix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process